These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 37004461
21. Opioid attentional bias and cue-elicited craving predict future risk of prescription opioid misuse among chronic pain patients. Garland EL, Howard MO. Drug Alcohol Depend; 2014 Nov 01; 144():283-7. PubMed ID: 25282309 [Abstract] [Full Text] [Related]
22. The impact of COVID-19 and rapid policy exemptions expanding on access to medication for opioid use disorder (MOUD): A nationwide Veterans Health Administration cohort study. Livingston NA, Davenport M, Head M, Henke R, LeBeau LS, Gibson TB, Banducci AN, Sarpong A, Jayanthi S, Roth C, Camacho-Cook J, Meng F, Hyde J, Mulvaney-Day N, White M, Chen DC, Stein MD, Weisberg R. Drug Alcohol Depend; 2022 Dec 01; 241():109678. PubMed ID: 36368167 [Abstract] [Full Text] [Related]
25. Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription-type opioid use disorder: secondary analysis of a Canadian treatment trial. Socias ME, Wood E, Le Foll B, Lim R, Choi JC, Mok WY, Bruneau J, Rehm J, Wild TC, Bozinoff N, Hassan A, Jutras-Aswad D, OPTIMA Research Group within the Canadian Research Initiative in Substance Misuse. Addiction; 2022 Oct 01; 117(10):2662-2672. PubMed ID: 35712892 [Abstract] [Full Text] [Related]
26. Initiation and Treatment Discontinuation of Medications for Opioid Use Disorder in Pregnant People Compared With Nonpregnant People. Xu KY, Jones HE, Schiff DM, Martin CE, Kelly JC, Carter EB, Bierut LJ, Grucza RA. Obstet Gynecol; 2023 Apr 01; 141(4):845-853. PubMed ID: 36897142 [Abstract] [Full Text] [Related]
28. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States. Sohn M, Talbert JC, Huang Z, Oser C, Freeman PR. Pain Physician; 2021 Mar 01; 24(2):E249-E256. PubMed ID: 33740362 [Abstract] [Full Text] [Related]
29. Pain and withdrawal are common among patients receiving medications for opioid use disorder and associated with pain catastrophizing, negative affect, and poor sleep. Berry MS, Dunn KE. Exp Clin Psychopharmacol; 2024 Aug 01; 32(4):386-391. PubMed ID: 38722586 [Abstract] [Full Text] [Related]
35. Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis. Eugenia Socias M, Choi JC, Fairbairn N, Johnson C, Wilson D, Debeck K, Brar R, Hayashi K. Int J Drug Policy; 2023 Aug 01; 118():104075. PubMed ID: 37271070 [Abstract] [Full Text] [Related]
36. Beliefs about medications for opioid use disorder among Florida criminal problem-solving court & dependency court staff. Andraka-Christou B, Atkins D. Am J Drug Alcohol Abuse; 2020 Nov 01; 46(6):749-760. PubMed ID: 32969757 [Abstract] [Full Text] [Related]
39. Management of opioid withdrawal and initiation of medications for opioid use disorder in the hospital setting. Carswell N, Angermaier G, Castaneda C, Delgado F. Hosp Pract (1995); 2022 Oct 01; 50(4):251-258. PubMed ID: 35837678 [Abstract] [Full Text] [Related]